Home / Companies / News /  SII launches first made-in-India HPV vaccine. Details here
Back

Serum Institute India on Tuesday launched the first made-in-India HPV vaccine on the occasion of India's national girl child day and cervical cancer awareness month. The vaccine was launched by Union Home Minister Amit Shah.

Tweeting about the same, Adar Poonawalla, CEO and chairman of the company, said, on the occasion of India's National Girl Child Day and Cervical Cancer Awareness Month, Serum Institute India is pleased to launch the first made-in-India HPV vaccine by the hands of our Hon'ble Home Minister Shri AmitShah and Prakash Singh.

Human papillomavirus (HPV) is a very common group of viruses. In most individuals, it does not cause any problems, but some types can cause genital warts or cancer. There are more than 100 different types.

Earlier in December last, Dr NK Arora, chairman of the Covid working group, National Technical Advisory Group on Immunisation (NTAGI) had said that it is expected India to get the HPV vaccine, by April at one-tenth cost.

Speaking to ANI, Dr Arora said, "There are two or three companies which are in the process (of manufacturing the vaccine in India) but the Serum Institute of India (SII) has already got the regulators' clearance and the vaccine should be available for our patients by April or May 2023."

"The vaccine should be available soon. I don't know the exact cost yet but am given to understand that the cost of the vaccine will be one-tenth of the internationally-branded vaccine currently available," he added.

Dr Arora further informed that almost 80,000 cases of cervical cancer occur in India every year.

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout